SK13542000A3 - Fragmenty chitinázy viažuce chitín - Google Patents

Fragmenty chitinázy viažuce chitín Download PDF

Info

Publication number
SK13542000A3
SK13542000A3 SK1354-2000A SK13542000A SK13542000A3 SK 13542000 A3 SK13542000 A3 SK 13542000A3 SK 13542000 A SK13542000 A SK 13542000A SK 13542000 A3 SK13542000 A3 SK 13542000A3
Authority
SK
Slovakia
Prior art keywords
chitinase
chitin
polypeptide
seq
amino acid
Prior art date
Application number
SK1354-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Patrick W. Gray
Larry W. Tjoelker
Original Assignee
Icos Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corporation filed Critical Icos Corporation
Publication of SK13542000A3 publication Critical patent/SK13542000A3/sk

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
SK1354-2000A 1998-03-12 1999-03-12 Fragmenty chitinázy viažuce chitín SK13542000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/039,198 US6200951B1 (en) 1998-03-12 1998-03-12 Chitinase chitin-binding fragments
PCT/US1999/005343 WO1999046390A1 (en) 1998-03-12 1999-03-12 Chitinase chitin-binding fragments

Publications (1)

Publication Number Publication Date
SK13542000A3 true SK13542000A3 (sk) 2001-07-10

Family

ID=21904197

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1354-2000A SK13542000A3 (sk) 1998-03-12 1999-03-12 Fragmenty chitinázy viažuce chitín

Country Status (14)

Country Link
US (3) US6200951B1 (no)
EP (1) EP1078073A1 (no)
JP (1) JP2002505882A (no)
CN (1) CN1357046A (no)
AU (1) AU763582B2 (no)
BR (1) BR9908724A (no)
CA (1) CA2323070A1 (no)
HU (1) HUP0101078A3 (no)
IL (1) IL138375A0 (no)
NO (1) NO20004522L (no)
PL (1) PL343197A1 (no)
RU (1) RU2000123559A (no)
SK (1) SK13542000A3 (no)
WO (1) WO1999046390A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7741000A (en) * 1999-09-30 2001-04-30 Icos Corporation Chitinase immunoglobulin fusion products
WO2002022686A2 (en) 2000-09-15 2002-03-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer Defensin-antigen fusion proteins
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CA2454342A1 (en) 2001-07-24 2003-02-06 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
US7632654B2 (en) * 2002-04-29 2009-12-15 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Means and methods for detecting endoglycosidase activity
NZ570989A (en) * 2002-05-16 2010-01-29 Sepracor Inc Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
CN1756838A (zh) * 2003-01-07 2006-04-05 杰诺瓦有限公司 心血管疾病中减少的分泌性多肽种类(来自壳三糖苷酶的片段)
WO2005005955A2 (en) * 2003-06-27 2005-01-20 New England Biolabs, Inc. Specific detection of chitin using chitin-binding domain
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US8377650B2 (en) * 2006-03-17 2013-02-19 The Norwegian University Of Life Sciences (Umb) Method of enhancing degradation of chitin
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
JP2011510308A (ja) * 2008-01-23 2011-03-31 リグスホスピタル バイオマーカーｙｋｌ−４０のレベルの測定により見出される生存予後に基く心血管疾患を患う個体の分類
WO2009092381A1 (en) 2008-01-23 2009-07-30 Herlev Hospital, Region Hovedstaden Ykl-40 as a general marker for non-specific disease
NZ592241A (en) 2008-09-15 2012-11-30 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
JP5036741B2 (ja) * 2009-02-18 2012-09-26 中原大學 翻訳段階で自己切断活性を有するポリヌクレオチド配列を同定するための方法およびシステム
WO2011135578A1 (en) 2010-04-28 2011-11-03 Chetan Balar Composition comprising chitin and tinosporin for use in the treatment of viral diseases
JP6654624B2 (ja) 2014-04-10 2020-02-26 エムイーピー・イークワイン・ソリューションズ・エルエルシー 糞便中の寄生虫卵の定量法
WO2020146514A1 (en) * 2019-01-08 2020-07-16 University Of Georgia Research Foundation Targeted nanoparticles and their uses related to fungal infections
CN109943621B (zh) * 2019-01-22 2022-07-01 美林美邦（厦门）生物科技有限公司 来自弧菌属的碱性几丁质酶在真菌染色中的应用
BR102020002165A2 (pt) * 2020-01-31 2021-11-30 Fundação Oswaldo Cruz Anticorpo, seu uso, composição farmacêutica o compreendendo, método de diagnóstico de infecções fúngicas, kit de diagnóstico de infecções fúngicas e método para tratamento de infecções fúngicas.
JPWO2023074415A1 (no) * 2021-10-25 2023-05-04

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587292A (en) 1987-05-22 1996-12-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnosis of fungal infections with a chitinase
US5258502A (en) * 1989-01-30 1993-11-02 Massachusetts Institute Of Technology Immobilization and purification of fusion proteins using chitin-binding ability
ES2151463T5 (es) 1989-12-22 2012-10-29 Merck Serono Sa Constructos de ADN para la activación y la modificación de la expresión de genes endógenos
AU664847B2 (en) 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
US5326561A (en) 1992-12-15 1994-07-05 Cornell Research Foundation, Inc. Antifungal synergistic combination of enzyme fungicide and non-enzymatic fungicide and use thereof
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5496934A (en) * 1993-04-14 1996-03-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acids encoding a cellulose binding domain
US5561051A (en) 1994-06-14 1996-10-01 American Cyanamid Company Screen for inhibitors of chitinase
US5928928A (en) 1995-06-07 1999-07-27 Universiteit Van Amsterdam Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
JPH11508139A (ja) 1996-03-29 1999-07-21 スミスクライン・ビーチャム・コーポレイション キトトリオシダーゼ
US20030017570A1 (en) 1996-06-14 2003-01-23 Patrick W. Gray Chitinase materials and methods

Also Published As

Publication number Publication date
HUP0101078A2 (hu) 2001-07-30
RU2000123559A (ru) 2002-12-27
US20030143216A1 (en) 2003-07-31
HUP0101078A3 (en) 2002-09-30
JP2002505882A (ja) 2002-02-26
CA2323070A1 (en) 1999-09-16
AU2998999A (en) 1999-09-27
US6399571B1 (en) 2002-06-04
NO20004522D0 (no) 2000-09-11
NO20004522L (no) 2000-11-01
WO1999046390A1 (en) 1999-09-16
IL138375A0 (en) 2001-10-31
EP1078073A1 (en) 2001-02-28
US6200951B1 (en) 2001-03-13
BR9908724A (pt) 2000-11-21
AU763582B2 (en) 2003-07-24
CN1357046A (zh) 2002-07-03
PL343197A1 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
SK13542000A3 (sk) Fragmenty chitinázy viažuce chitín
Galjart et al. Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases
JP4503708B2 (ja) ヒト血漿ヒアルロニダーゼ
AU752642B2 (en) Antibody against LAR phosphatase subunit
JP4145356B2 (ja) Ｐ―セレクチンリガンド蛋白
EP1396542B1 (en) P-Selectin Ligand Protein
HU228743B1 (en) Treatment of alpha-galactosidase a deficiency
EA015009B1 (ru) АНТИГЕНСВЯЗЫВАЮЩИЕ МОЛЕКУЛЫ, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ АФФИННОСТЬЮ К СВЯЗЫВАНИЮ С Fc-РЕЦЕПТОРОМ И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ
JPH07507679A (ja) セレクチンリガンド
WO1991007483A2 (en) Mammalian pancreatic cholesterol esterase
JP2002524099A (ja) 脈管形成の調節における内皮細胞表面受容体活性の調節
US6372212B1 (en) Chitinase materials and methods
US5648465A (en) Cloning and expression of neurocan, a chondroitin sulfate proteoglycan
WO1994003601A9 (en) Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
WO2013001819A1 (ja) 可溶性インテグリンα４変異体
WO1993021330A1 (en) Human glutamine:fructose-6-phosphate amino-transferase
WO1998054333A2 (en) Mammalian caax processing enzymes
WO2005071070A2 (en) Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors
CZ20003308A3 (cs) Chitin-vazebné fragmenty chitinázy
WO2001046415A1 (fr) Polypeptides de type tachykinine et utilisation associee
US20030190739A1 (en) Tankyrase2 materials and methods
MXPA98010619A (en) Materials and methods for the production of quitin
Selvanayagam Cloning, sequencing and expression of cDNA encoding two lysosomal membrane proteins, and generation of monoclonal antibodies against them